Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.
Press releases published on October 19, 2025
Ryoncil® Net Revenues Increase 69% in Second Quarter Post Launch
NEW YORK, Oct. 19, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided highlights of its recent activities for the first quarter ended September 30, …
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: The Whole FX Team is Now in Full Sprint Mode for the Year-End Off-Line Target for the Company’s First FX Super One Vehicle
The UAE launch of the FX Super One will take place on October 28 at the Armani Hotel, Burj Khalifa, Dubai. LOS ANGELES, Oct. 19, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or the “Company”), a …
Crypto News (Live): Blazpay’s Crypto Presale Ignites as TRON and Avalanche Investors Search for the Next Big Crypto Coin
PANAMA CITY, Oct. 19, 2025 (GLOBE NEWSWIRE) -- The crypto market continues to heat up in mid-October 2025 as investors scan for the next big crypto coin that can deliver exponential returns ahead of the next bull cycle. While TRON (TRX) and Avalanche (AVAX …
Rockcliffe Labs Launches Canada’s First Venture-Building Platform for Biotechnology and Life Sciences with Mission to Create 100 Companies
TORONTO, Oct. 19, 2025 (GLOBE NEWSWIRE) -- Rockcliffe Labs Inc. (“Rockcliffe Labs”), a Canadian biotechnology venture creation platform, announces the launch of its first dedicated program designed to transform breakthrough scientific discoveries into …
Avacta Therapeutics Presents Compelling Phase 1a Data for Faridoxorubicin and the pre|CISION® Platform at the European Society of Medical Oncology Annual Congress
Median progression free survival (PFS) has not been reached in the cohort of patients with salivary gland cancer with PFS follow up suggesting a more than doubling of the benchmark PFS and a disease control rate of 91% No maximum tolerated dose reached …
Mutuum Finance (MUTM) Progresses Toward Q4 2025 Testnet Launch With $17.6 Million Raised
Dubai, UAE, Oct. 19, 2025 (GLOBE NEWSWIRE) -- Ethereum-based Mutuum Finance (MUTM) continues to make headway in the decentralized finance sector as it advances toward the launch of its Version 1 (V1) protocol on the Sepolia testnet, scheduled for Q4 2025. …
Replimune Highlights Acral Melanoma Data for RP1 plus Nivolumab at the ESMO Congress 2025
WOBURN, Mass., Oct. 19, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced data from a new ad hoc analysis from the IGNYTE …
RAPT Therapeutics to Report Topline Data from Phase 2 Clinical Trial of RPT904 in Chronic Spontaneous Urticaria (CSU)
SOUTH SAN FRANCISCO, Calif., Oct. 19, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living …
FBS AI Assistant Helps Traders Skip Market Noise and Focus on Strategy
SINGAPORE, Oct. 19, 2025 (GLOBE NEWSWIRE) -- FBS, a leading global broker, introduces the FBS AI Assistant, an intelligent feature in the FBS app designed to help traders skip the market noise. According to the team, trading often means dealing with …